Immune-Mediated Hemolytic Anaemia (IMHA) in dogs is a serious, potentially life-threatening condition. In this disease, the immune system mistakenly attacks and destroys the dog’s own red blood cells. Red blood cells (RBCs) carry oxygen throughout the body. So, their destruction can lead to weakness, organ damage, yellowing of skin or jaundice, and in severe cases, death if not treated promptly.
Understanding how IMHA works, recognising early symptoms, and knowing what to expect from treatment can significantly improve outcomes. This comprehensive blog covers everything pet parents need to know about canine IMHA, from diagnosis to long-term management.
How Immune-Mediated Haemolytic Anaemia Affects a Dog’s Immune System and Red Blood Cells
In a healthy dog, the immune system protects the body from harmful invaders such as bacteria, viruses, and parasites. In dogs with IMHA, the immune system becomes dysregulated and mistakenly identifies the body’s own red blood cells as foreign threats.
Antibodies attach to the surface of red blood cells. This triggers:
- Destruction of red blood cells in the spleen and liver (extravascular haemolysis)
- Destruction directly within the bloodstream (intravascular haemolysis)
As red blood cells are destroyed faster than the body can replace them, dogs develop anaemia. The resulting oxygen shortage affects vital organs, including the brain, heart, kidneys, and liver.
IMHA in dogs can develop rapidly and worsen within hours to days, making early intervention critical.
Suggested Read: 15 Heat-Tolerant Dog Breeds for the Indian Climate
What Happens in a Dog’s Body During Canine Haemolytic Anaemia
When red blood cells break down, several dangerous processes occur:
- Reduced oxygen delivery: Tissues become oxygen-starved.
- Release of haemoglobin: Free haemoglobin enters the bloodstream and urine.
- Bilirubin buildup: Breakdown products accumulate, potentially causing jaundice.
- Inflammatory cascade: The immune attack triggers widespread inflammation.
- Increased clotting risk: Dogs with IMHA are highly prone to life-threatening blood clots (thromboembolism).
The body attempts to compensate by producing more red blood cells in the bone marrow. However, if destruction outpaces production, severe anaemia develops.
In some cases, immune-mediated haemolytic anaemia in dogs can also suppress platelet counts, further complicating the condition.
Early and Advanced Symptoms of IMHA in Dogs That Pet Parents Should Recognise
Early Symptoms May Include:
- Lethargy or weakness
- Reduced appetite
- Pale gums
- Rapid breathing or panting
- Mild fever
Advanced Or Emergency Symptoms:
- Yellowing of gums, eyes, or skin (jaundice)
- Dark or orange-coloured urine
- Collapse or extreme weakness
- Rapid heart rate
- Laboured breathing
- Distended abdomen
- Cold extremities
- Disorientation or seizures
- Fever
IMHA symptoms in dogs can worsen within hours, making early recognition critical.
Suggested Read: Why is your dog not eating: What can you do?
Common Causes and Risk Factors Behind Dogs’ Immune-Mediated Haemolytic Anaemia
Immune-mediated haemolytic anaemia is classified as primary or secondary, depending on whether a trigger is identified.
Primary (Idiopathic) IMHA in Dogs
Primary immune-mediated haemolytic anaemia in dogs occurs without a clearly identifiable cause. The immune system spontaneously becomes overactive and targets red blood cells. This form accounts for a large proportion of IMHA cases and is unpredictable.
The term “idiopathic” simply means the exact cause is unknown.
Secondary IMHA Caused by Infections, Medications, or Vaccines
Secondary IMHA in dogs is triggered by another condition, such as:
- Tick-borne diseases
- Certain bacterial or viral infections
- Medications (such as sulfa drugs or penicillin-based antibiotics)
- Toxins
- Cancer
- Recent vaccinations (rare but documented)
Treating the underlying cause is crucial in secondary immune-mediated haemolytic anaemia.
Breeds More Prone to Haemolytic Disease in Dogs
Certain breeds have a higher risk, including:
- Cocker Spaniels
- Poodles
- Old English Sheepdogs
- Dachshunds
- Irish Setters
However, any breed or mixed-breed dog can develop immune-mediated haemolytic anaemia.
How Veterinarians Diagnose IMHA in Dogs and Confirm Haemolytic Anaemia
Diagnosis of canine haemolytic anaemia requires confirming two things:
- The dog is anaemic.
- The immune system is destroying red blood cells
Prompt diagnostic testing is crucial, especially in critically ill dogs.
Blood Tests and Diagnostic Markers for Canine Haemolytic Anaemia
Common diagnostic tools include:
- Complete Blood Count (CBC) – Confirms anaemia and checks white blood cell and platelet levels
- Packed Cell Volume (PCV) – Measures the percentage of red blood cells in blood
- Blood smear – May reveal spherocytes (abnormally shaped red cells)
- Saline agglutination test – Detects antibody-coated red cells clumping together
- Coombs test – Identifies antibodies attached to red blood cells
- Bilirubin levels – Elevated in hemolysis
Regenerative anaemia (the presence of immature red blood cells) suggests that the bone marrow is responding appropriately.
Additional Tests Used to Identify Underlying Triggers
Depending on the case, vets may also perform:
- Tick disease screening
- Abdominal ultrasound
- Chest X-rays
- Urinalysis
- Clotting tests
Identifying triggers helps guide treatment and prognosis.
Suggested Read: Which Dogs Can Donate Blood?
Treatment Options for IMHA in Dogs and What to Expect During Hospitalisation
Most dogs with immune-mediated haemolytic anaemia require intensive hospitalisation, especially during the first critical days.
Treatment goals include:
- Stopping immune destruction
- Stabilising red blood cell levels
- Preventing blood clots
- Supporting organ function
Immunosuppressive Medications Used for Dog Haemolytic Anaemia
The cornerstone of IMHA treatment is immune suppression:
- Corticosteroids to reduce immune attack
- Additional immunosuppressive drugs if needed
These medications slow the destruction of red blood cells but require careful monitoring.
Steroids are typically started at high doses and gradually tapered over several months. Side effects may include increased thirst and urination, increased appetite, panting, and increased susceptibility to infections.
Blood Transfusions and Supportive Care for Severe IMHA Cases
Dogs with life-threatening anaemia often require blood transfusions to stabilise oxygen levels. Additional supportive care may include:
- Blood transfusions
- Oxygen therapy
- IV fluids
- Temperature regulation
- Nutritional support
Transfusions do not cure immune-mediated haemolytic anaemia in dogs. They buy time while immunosuppressive medications take effect.
Managing Complications Such as Blood Clots and Organ Damage
Immune-mediated haemolytic anaemia in dogs increases the risk of:
- Blood clots
- Liver damage
- Kidney injury
- Pancreatitis
Preventive medications and frequent monitoring are often required.
IMHA Dog Diet Considerations During Treatment and Recovery
While diet alone cannot treat IMHA in dogs, proper nutrition plays an important supportive role. Key considerations include:
- Highly digestible, nutrient-dense food
- Adequate protein to support RBC regeneration
- Adequate iron (if recommended by a veterinarian)
- Omega-3 fatty acids for anti-inflammatory support
- Encourage appetite without forcing food
- Avoid raw diets during immunosuppressive therapy
Dogs on steroids often experience increased appetite and weight gain. Controlled feeding and portion management are essential.
Always consult a pet health expert before adding supplements, as some may interfere with medications.
Recovery Timeline and Long-Term Management of IMHA in Dogs
Recovery is slow and variable, often taking weeks to months.
Monitoring Relapse Risks in Dogs With Immune-Mediated Haemolytic Anaemia
Relapse is possible, especially during medication tapering. Dogs require:
- Regular blood tests
- Gradual dose reductions (dose tapering)
- Close observation for early signs of recurrence
Lifestyle Adjustments for Dogs Living With IMHA
Long-term care of immune-mediated haemolytic anaemia in dogs may include:
- Limited activity during recovery
- Reduced stress
- Avoiding unnecessary vaccinations or medications
- Maintaining consistent routines
- Monitoring energy levels and appetite
Many dogs live good quality lives with careful management.
Prognosis and Survival Rates for Dogs Diagnosed With IMHA
Prognosis varies widely and depends on:
- Speed of diagnosis
- Severity at presentation
- Presence of blood clots
- Underlying cause
- Speed of treatment
- Response to treatment
- Presence of complications
Survival rates have improved significantly with early, aggressive care. But IMHA in dogs remains a serious condition with guarded prognosis.
When IMHA in Dogs Becomes a Medical Emergency
Seek emergency care immediately if your dog shows:
- Sudden weakness or collapse
- Pale or yellow gums
- Dark urine
- Rapid breathing
- Unresponsiveness
- Dark red/brown urine
Immune-mediated haemolytic anaemia in dogs can progress rapidly and should never be monitored at home.
If your dog shows signs of anaemia or sudden weakness, an immediate consultation at the nearest 24/7 dog emergency care can be life-saving.
Final Takeaway: About Immune-Mediated Haemolytic Anaemia in Dogs
Immune-Mediated Haemolytic Anaemia in dogs is a complex autoimmune disease requiring rapid diagnosis, intensive treatment, and long-term management. Although the condition can be frightening for pet parents, advances in veterinary medicine have significantly improved survival rates.
Close communication with your veterinarian, strict adherence to medication protocols, and vigilant at-home monitoring can make a life-saving difference. With prompt care and ongoing management, many dogs with IMHA go on to enjoy meaningful, happy lives.
Frequently Asked Questions: About Immune-Mediated Haemolytic Anaemia in Dogs
Is IMHA in dogs always fatal?
No. IMHA in dogs is serious and potentially life-threatening. But many dogs recover with prompt and aggressive treatment. Survival rates improve significantly with early intervention and close monitoring.
Can IMHA in dogs come back after treatment?
Yes. Relapse is possible, particularly during medication tapering. Some dogs experience one episode, while others may have multiple recurrences.
What triggers IMHA in dogs suddenly?
Triggers may include infections, medications, cancer, or immune dysregulation. In many cases, no clear cause is identified (idiopathic immune-mediated haemolytic anaemia).
How long can a dog live with immune-mediated haemolytic anaemia?
Dogs that respond well to treatment can live for years after diagnosis. Long-term management and regular monitoring are essential to prevent relapse.
Can diet alone help manage IMHA in dogs?
No. IMHA requires medical treatment with immunosuppressive drugs. Diet can support recovery, but cannot stop the immune destruction of red blood cells.
References
Blais, M.-C. . (2019). Clinical Approach to Canine Immune-Mediated Anemia, Including Benefits and Risks of Transfusions. Vin.com. https://www.vin.com/apputil/content/defaultadv1.aspx?pId=24437&catId=137422&id=9382871&ind=161&objTypeID=17
Goggs, R., Dennis, S. G., Di Bella, A., Humm, K. R., McLauchlan, G., Mooney, C., Ridyard, A., Tappin, S., Walker, D., Warman, S., Whitley, N. T., Brodbelt, D. C., & Chan, D. L. (2015). Predicting Outcome in dogs with Primary Immune-Mediated Hemolytic Anemia: Results of a Multicenter Case Registry. Journal of Veterinary Internal Medicine, 29(6), 1603–1610. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864895/
Kendall, A. (2024, July). Regenerative Anemias in Animals. MSD Veterinary Manual; MSD Veterinary Manual. https://www.msdvetmanual.com/circulatory-system/anemia/regenerative-anemias-in-animals#Anemia-Due-to-Hemolysis_v92008174
Skelly, B., & Swann, J. (2016). Canine autoimmune hemolytic anemia: management challenges. Veterinary Medicine: Research and Reports, Volume 7, 101-112. https://www.dovepress.com/canine-autoimmune-hemolytic-anemia-management-challenges-peer-reviewed-fulltext-article-VMRR
Swann, J. W., Garden, O. A., Fellman, C. L., Glanemann, B., Goggs, R., LeVine, D. N., Mackin, A. J., & Whitley, N. T. (2019). ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs. Journal of Veterinary Internal Medicine, 33(3). https://pmc.ncbi.nlm.nih.gov/articles/PMC6524099/
